acquired
Stage
5
Investors
About
Allena Pharmaceuticals is a late-stage clinical company developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and common metabolic and renal diseases.
Explore Allena Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.